论文部分内容阅读
目的对小儿咳嗽变异性哮喘的治疗方法和治疗效果进行探讨和分析。方法将54例经临床确诊的小儿咳嗽变异性哮喘患儿纳入本次选择范围,将患儿分为治疗组和对照组,治疗组29例患儿接受氨溴索、酮替芬和消旋山莨菪碱(654-2)治疗,对照组25例患儿接受氨溴索、酮替芬治疗,分别对两组患儿的临床用药效果进行比较和分析。结果治疗组27例患儿治疗有效,占93.10%,对照组19例患儿治疗有效,治疗有效率76%,治疗组患儿症状消失时间明显短于对照组,病情复发率明显低于对照组,两组患儿治疗效果、症状消失时间以及病情复发率差异具有统计学意义(P<0.05)。结论将氨溴索、酮替芬和654-2联合应用于咳嗽变异性哮喘患儿的治疗当中临床疗效显著。
Objective To investigate and analyze the treatment and treatment effect of pediatric cough variant asthma. Methods Fifty-four children with clinically diagnosed pediatric cough variant asthma were enrolled in this study. The children were divided into treatment group and control group. In the treatment group, 29 patients received ambroxol, ketotifen and racemic Scopolamine (654-2) treatment, control group of 25 patients received ambroxol and ketotifen treatment, respectively, the clinical efficacy of the two groups were compared and analyzed. Results The treatment group, 27 cases of children effective treatment, accounting for 93.10%, 19 cases of children in the control group were treated effectively, the effective rate of 76%, the treatment group, children with symptoms disappeared significantly shorter than the control group, the disease recurrence rate was significantly lower than the control group There was significant difference between the two groups in the treatment effect, the disappearance of symptoms and the recurrence rate (P <0.05). Conclusion The combination of ambroxol, ketotifen and 654-2 in children with cough variant asthma has a significant clinical effect.